18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis
1 other identifier
observational
11
0 countries
N/A
Brief Summary
A total of 11 patients confirmed with tuberculous pericarditis were enrolled in this study to analyze the diagnostic value of 18F-FDG PET/CT for tuberculous pericarditis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedFirst Submitted
Initial submission to the registry
July 11, 2022
CompletedFirst Posted
Study publicly available on registry
July 14, 2022
CompletedJuly 14, 2022
July 1, 2022
7.2 years
July 11, 2022
July 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the diagnostic sensitivity of 18F-FDG PET/CT for tuberculous pericarditis
the diagnostic sensitivity of 18F-FDG PET/CT for tuberculous pericarditis
01,2015-02,2022
Study Arms (2)
tuberculous pericarditis with 18F-FDG uptake
patients confirmed with tuberculous pericarditis presenting 18F-FDG uptake
tuberculous pericarditis without 18F-FDG uptake
patients confirmed with tuberculous pericarditis presenting no 18F-FDG uptake
Interventions
18F-FDG intravenous injection
Eligibility Criteria
A total of 11 patients confirmed with tuberculous pericarditis were enrolled in this study.
You may qualify if:
- patients confirmed as tuberculous pericarditis through follow-up.
You may not qualify if:
- patients confirmed as other pericarditis through follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- director of the nuclear medicine
Study Record Dates
First Submitted
July 11, 2022
First Posted
July 14, 2022
Study Start
January 1, 2015
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
July 14, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share